Aptose Biosciences Inc. (APTOF)

CIK 882361 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aptose Biosciences Inc..

Recent SEC filings

FiledFormAccession number
Jul 2, 202640000912282-26-000902
Jul 1, 202640000912282-26-000894
Jul 1, 20268-K0001193125-26-291114
Jul 1, 2026SC 13E3/A0001193125-26-291467
Jul 1, 202640000912282-26-000896
Jul 1, 202615-12G0001193125-26-291469
Jul 1, 202640000912282-26-000897
Jul 1, 20268-K0001171843-26-004406
Jul 1, 202640000912282-26-000900
Jul 1, 202640000912282-26-000893
Jul 1, 202640000912282-26-000895
Jul 1, 202640000912282-26-000898
Jun 15, 20268-K0001171843-26-004119
May 29, 20268-K0001171843-26-003778
May 13, 202610-Q0001193125-26-221955
May 13, 20268-K0001171843-26-003381
Apr 30, 20268-K0001171843-26-002877
Apr 1, 2026SC 13E3/A0001193125-26-137914
Mar 31, 202610-K0001193125-26-135012
Mar 31, 20268-K0001193125-26-134870
Mar 31, 20268-K0001171843-26-002103
Mar 23, 2026RW0001193125-26-119982
Mar 23, 20268-K0001193125-26-119951
Mar 23, 20268-K0001171843-26-001837
Mar 19, 20268-K0001171843-26-001777